PDB15 COMPARATIVE COST-UTILITY ANALYSIS OF LONG-ACTING INSULIN ANALOGUE (INSULIN DETEMIR) AND NPH INSULIN FOR THE TREATMENT OF TYPE 1 AND TYPE 2 DIABETES AND THE BUDGET IMPACT ANALYSIS OF INSULIN ANALOGUE REIMBURSEMENT IN POLAND

Autor:	Walczak, J, Pawlik, D, Jasinska, A, Garbacka, M, Kedzior, J, Fundament, T, Malczak, I, Dardzinski, W, Skrzekowska-Baran, I, Czech, M, Nogas, G
Zdroj:	In Value in Health 2008 11(6):A500-A500
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect Plný text